As of November 7, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Change Agents Corporation. The largest reported stake is Armistice Capital, LLC's, at 9.99%. 4 filings are on record since March 5, 2026 (Schedule 13G, August 14, 2026).
Sell to companies like Change Agents Corporation? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Armistice Capital, LLC · Sole voting: 0 · Shared voting: 1,598,749 · Sole dispositive: 0 · Shared dispositive: 1,598,749 · SCHEDULE 13G, 2026-08-14
- · Reporting person: Mitchell P. Kopin · Sole voting: 0 · Shared voting: 632,752 · Sole dispositive: 0 · Shared dispositive: 632,752 · SCHEDULE 13G/A, 2026-08-13
- · Holder: Armistice Capital, LLC · Percent: 9.99% · SCHEDULE 13G
- · Holder: Mitchell P. Kopin · Percent: 7% · SCHEDULE 13G
Change Agents Corporation has 4 Schedule 13D or 13G filings on record since 2026-03-05. 1 holder's latest filing reports 5% or more of common stock, $0.0001 par value. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.99% | 1,598,749 | SCHEDULE 13G, 2026-08-14 | 2026-06-30 |
| 4.99% | 632,752 | SCHEDULE 13G/A, 2026-08-13 | 2026-06-30 |
Holding shares or following this stake? See who's behind Change Agents Corporation and the warning signs.
Free to see. No signup.
Keep reading
More on Change Agents Corporation and the records around it.
Change Agents Corporation elsewhere on the record
- Leadership changes Oct 2026
- Company profile and every filing Mar 2026
- Form D filing Mar 2026
- Who owns it
Companies that share a holder
- Mitchell P. Kopin also filed stake reports on 55 other companies: SCWorx Corp. (Sep 2026), NFT Limited (Aug 2026), Silexion Therapeutics Corp (Aug 2026)
- Armistice Capital, LLC also filed stake reports on 120 other companies: Autolus Therapeutics plc (Aug 2026), Bicycle Therapeutics plc (Aug 2026), BioXcel Therapeutics, Inc. (Aug 2026)
Watch Change Agents Corporation
Get an email when Change Agents Corporation files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Change Agents Corporation?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Change Agents Corporation: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Change Agents Corporation covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
9 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 0 | 1,598,749 | 0 | 1,598,749 | SCHEDULE 13G, 2026-08-14 |
| Steven Boyd | 0 | 1,598,749 | 0 | 1,598,749 | SCHEDULE 13G, 2026-08-14 |
| Mitchell P. Kopin | 0 | 632,752 | 0 | 632,752 | SCHEDULE 13G/A, 2026-08-13 |
| Daniel B. Asher | 0 | 632,752 | 0 | 632,752 | SCHEDULE 13G/A, 2026-08-13 |
| Intracoastal Capital LLC | 0 | 632,752 | 0 | 632,752 | SCHEDULE 13G/A, 2026-08-13 |
The latest filing identifies Change Agents Corporation by CUSIP 05344R302 and gives its principal executive office as 4400 Route 9 South, Suite 3100, Freehold, NJ 07728 (SCHEDULE 13G, 2026-08-14).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-03-05 | Mitchell P. Kopin | 7% | SCHEDULE 13G |
| 2026-05-15 | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-08-13 | Mitchell P. Kopin | 4.99% | SCHEDULE 13G/A |
| 2026-08-14 | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
Questions about who owns Change Agents Corporation
Who owns Change Agents Corporation?
On this page, one holder's latest ownership filing reports 5% or more of Change Agents Corporation: Armistice Capital, LLC (9.99%, Schedule 13G, filed 2026-08-14).
When did Armistice Capital, LLC buy into Change Agents Corporation?
The filings give report dates, not purchase dates. The earliest filing from Armistice Capital, LLC on this page is the Schedule 13G, filed 2026-05-15, reporting 9.99%; its latest, Schedule 13G filed 2026-08-14, reports 9.99%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 4 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Change Agents Corporation
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 5, 2026 | Leadership change: Luisa Ingargiola appointed, Chief Executive Officer | — | Leadership changes | Source |
| October 16, 2026 | Leadership change: Eric Weisblum appointed, Director | — | Leadership changes | Source |
| October 8, 2026 | Leadership change: Meng Li departs, Chief Executive Officer, and 1 more | — | Leadership changes | Source |
| June 4, 2026 | Leadership change: Luisa Ingargiola appointed, Chief Strategy Officer, and 1 more | — | Leadership changes | Source |
| March 12, 2026 | Form D, private offering | $3.25M sold | Form D page | Source |
Change Agents Corporation: every filing and event
Tools for this story
Each opens in a new tab, filled in for Change Agents Corporation. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.